Covered recipient · General Payments record
LINDA AUGUSTA HEFFERNAN
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2018–2024
$3,259.63
- Reported across 161 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $328.28 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $100.04 | 6 |
| ORGANOGENESIS INC. | $40.59 | 1 |
| Arcutis Biotherapeutics, Inc. | $36.80 | 2 |
| E.R. Squibb & Sons, L.L.C. | $35.79 | 2 |
| Regeneron Healthcare Solutions, Inc. | $30.69 | 1 |
| UCB, Inc. | $25.06 | 1 |
| Tempus AI, Inc | $18.02 | 1 |
| Stemline Therapeutics Inc. | $14.15 | 1 |
| Amgen Inc. | $13.97 | 1 |
| Galderma Laboratories, L.P. | $13.17 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.64 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103899322 | CMS |
| ABBVIE INC. | $17.32 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103899324 | CMS |
| ABBVIE INC. | $16.33 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103899326 | CMS |
| ABBVIE INC. | $22.31 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103899328 | CMS |
| ABBVIE INC. | $14.31 | 08/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103899330 | CMS |
| ABBVIE INC. | $13.13 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103899332 | CMS |
| Amgen Inc. | $13.97 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117274551 | CMS |
| Arcutis Biotherapeutics, Inc. | $14.64 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1121060177 | CMS |
| Arcutis Biotherapeutics, Inc. | $22.16 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1121060179 | CMS |
| E.R. Squibb & Sons, L.L.C. | $21.76 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101427848 | CMS |
| E.R. Squibb & Sons, L.L.C. | $14.03 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101427870 | CMS |
| Galderma Laboratories, L.P. | $13.17 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145303457 | CMS |
| Organogenesis Inc. | $40.59 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145430977 | CMS |
| Regeneron Healthcare Solutions, Inc. | $30.69 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114067457 | CMS |
| Stemline Therapeutics Inc. | $14.15 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142961555 | CMS |
| Tempus AI, Inc | $18.02 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150166126 | CMS |
| UCB, Inc. | $25.06 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143078560 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.